Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registryHjalmar Flygt, Johan Richter, Ulla Olsson‐Strömberg et al.|British Journal of Haematology|2021Cited by 15
The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based studyTorsten Dahlén, Fredrik Nyberg, Leif Stenke et al.|Leukemia|2023Cited by 5